These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31343304)

  • 1. Targeting transthyretin amyloidosis in the eye with next-generation stabilizers: AT40 displays potent TTR stabilization in the human vitreous.
    Bezerra F; Simões CJV; Beirão JM; Saraiva MJ; Brito RMM; Almeida MR
    Amyloid; 2019; 26(sup1):73-74. PubMed ID: 31343304
    [No Abstract]   [Full Text] [Related]  

  • 2. Lead optimization of resilient next-generation transthyretin stabilizers for multiple target-product profiles: approaching the CNS.
    Simões CJV; Almeida ZL; Cardoso AL; Bezerra F; Almeida MR; Beirão J; Pinho E Melo TMVD; Saraiva MJ; Brito RMM
    Amyloid; 2019; 26(sup1):77-78. PubMed ID: 31343302
    [No Abstract]   [Full Text] [Related]  

  • 3. Curcumin could reduce the monomer of TTR with Tyr114Cys mutation via autophagy in cell model of familial amyloid polyneuropathy.
    Li H; Zhang Y; Cao L; Xiong R; Zhang B; Wu L; Zhao Z; Chen SD
    Drug Des Devel Ther; 2014; 8():2121-8. PubMed ID: 25382970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncovering the Neuroprotective Mechanisms of Curcumin on Transthyretin Amyloidosis.
    Ferreira N; Saraiva MJ; Almeida MR
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene.
    Roe RH; Fisher Y; Eagle RC; Fine HF; Cunningham ET
    Ophthalmology; 2007 Nov; 114(11):e33-7. PubMed ID: 17980738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous amyloidosis in two sisters as the indication of transthyretin-related familial form of systemic amyloidosis among liver transplantation candidates.
    Niemczyk R; Brydak-Godowska J; Kecik D; Wagner T; Lewandowski P; Kecik M; Zygier D; Ołdakowska-Jedynak U
    Transplant Proc; 2009 Oct; 41(8):3085-7. PubMed ID: 19857683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considering amyloidosis in patients with clinically unresponsive vitreous inflammation (Oculoleptomeningeal amyloidosis in 3 individuals with transthyretin variant Tyr69His. Vol. 44[3]).
    Roe RH; Cunningham ET
    Can J Ophthalmol; 2010 Feb; 45(1):81. PubMed ID: 20130721
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of familial amyloid polyneuropathy due to Phe33Val TTR with vitreous involvement as the initial manifestation.
    Kono S; Manabe Y; Tanaka T; Fujii D; Sakai Y; Narai H; Omori N; Ueda M; Ando Y; Abe K
    Intern Med; 2010; 49(12):1213-6. PubMed ID: 20558946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid and vitreous body exposure to orally administered tafamidis in hereditary ATTRV30M (p.TTRV50M) amyloidosis patients.
    Monteiro C; Martins da Silva A; Ferreira N; Mesgarzadeh J; Novais M; Coelho T; Kelly JW
    Amyloid; 2018 Jun; 25(2):120-128. PubMed ID: 29993288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease.
    Adams D; Koike H; Slama M; Coelho T
    Nat Rev Neurol; 2019 Jul; 15(7):387-404. PubMed ID: 31209302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transthyretin Ala36Pro mutation in a Chinese pedigree of familial transthyretin amyloidosis with elevated vitreous and serum vascular endothelial growth factor.
    Zou X; Dong F; Zhang S; Tian R; Sui R
    Exp Eye Res; 2013 May; 110():44-9. PubMed ID: 23438977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic Strategies for Hereditary Transthyretin Amyloidosis].
    Ueda M
    Brain Nerve; 2023 May; 75(5):539-541. PubMed ID: 37194527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial amyloid polyneuropathy associated with the novel transthyretin variant Arg34Gly.
    Levy J; Hawkins PN; Rowczenio D; Godfrey T; Stawell R; Zamir E
    Amyloid; 2012 Dec; 19(4):201-3. PubMed ID: 22973891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solar Eruption in Hereditary Transthyretin Amyloidosis.
    Rousseau A; Bodaghi B; Labetoulle M
    Ophthalmology; 2019 Mar; 126(3):371. PubMed ID: 30803513
    [No Abstract]   [Full Text] [Related]  

  • 15. Tafamidis in hereditary ATTR amyloidosis - our experience on monitoring the ocular manifestations.
    Casal I; Monteiro S; Beirão JM
    Amyloid; 2016 Dec; 23(4):262-263. PubMed ID: 27748624
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytodiagnosis and protein typing of amyloid from a vitreous washing: initial diagnostic workup of hereditary amyloidosis.
    Coppock JD; Dusenbery AC; Elghawy O; Fellenstein LA; Frierson HF; Shildkrot Y
    J Am Soc Cytopathol; 2020; 9(3):173-176. PubMed ID: 32113804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation and management of vitreous and nerve amyloid in familial amyloid polyneuropathy due to variant transthyretin, Phe33Val.
    Gregory ME; Carey M; Hawkins PN; Banerjee S; Gillmore JD
    Br J Ophthalmol; 2008 Jan; 92(1):34-5, 142. PubMed ID: 18156374
    [No Abstract]   [Full Text] [Related]  

  • 18. Transthyretin (ATTR) amyloidosis nephropathy: lessons from a TTR stabilizer molecule.
    Rocha A; Silva A; Cardoso M; Beirão I; Alves C; Teles P; Coelho T; Lobato L
    Amyloid; 2017 Mar; 24(sup1):81-82. PubMed ID: 28434370
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of the effects of transthyretin peptide inhibitors in Drosophila models of neuropathic ATTR.
    Saelices L; Pokrzywa M; Pawelek K; Eisenberg DS
    Neurobiol Dis; 2018 Dec; 120():118-125. PubMed ID: 30213731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study.
    Ando Y; Sekijima Y; Obayashi K; Yamashita T; Ueda M; Misumi Y; Morita H; Machii K; Ohta M; Takata A; Ikeda S
    J Neurol Sci; 2016 Mar; 362():266-71. PubMed ID: 26944161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.